A CLUSTER OF FEVER AND HYPOTENSION ON A SURGICAL INTENSIVE-CARE UNIT RELATED TO THE CONTAMINATION OF PLASMA EXPANDERS BY CELL-WALL PRODUCTSOF BACILLUS-STEAROTHERMOPHILUS
A. Trilla et al., A CLUSTER OF FEVER AND HYPOTENSION ON A SURGICAL INTENSIVE-CARE UNIT RELATED TO THE CONTAMINATION OF PLASMA EXPANDERS BY CELL-WALL PRODUCTSOF BACILLUS-STEAROTHERMOPHILUS, Infection control and hospital epidemiology, 16(6), 1995, pp. 335-339
OBJECTIVE: To evaluate an outbreak of fever and hypotension after card
iac surgical procedures and the role of polygeline, a plasma expander.
DESIGN: Unmatched case-control study. SETTING: A six-bed cardiac surg
ery intensive care unit (SICU) of the Hospital Clinic of Barcelona (Sp
ain), a 940-bed public teaching hospital. PATIENTS: Eight cases and 25
control patients admitted to the SICU over a 4-week epidemic period.
MAIN OUTCOME MEASURES: Development of hypotension (systolic blood pres
sure less than or equal to 90 mm Hg or a drop of 40 mm Hg from baselin
e systolic blood pressure) and fever (axillary temperature >38.5 degre
es C) within 24 hours of a cardiac surgical procedure. RESULTS: The si
ngle risk factor significantly different between cases and controls wa
s the total volume of polygeline used throughout the surgical procedur
e for extracorporeal circulation: a median of 1,250 mL (mean, 1,312.5
+/- 842.5 mL) in cases versus 500 mL (mean, 566.0 +/- 159.9 mL) in con
trols (P=.0029). By multiple logistic regression analysis, polygeline
use was the single risk factor significantly related to the outcome (o
dds ratio, 8.75; CI95, 1.36 to 56.2; P=.01). Neither blood cultures fr
om patients nor cultures of the polygeline used yielded growth of any
microorganism. Stopping use of the implicated polygeline lot controlle
d the outbreak. CONCLUSIONS: Use of polygeline was associated with an
outbreak of fever and hypotension in a SICU. Information from the manu
facturer indicated the likelihood of contamination of the product with
Bacillus stearothermophilus components. The manufacturer has since ch
anged the production and control processes, and no further adverse eve
nts have been seen (Infect Control Hosp Epidemiol 1995;16:335-339).